Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 26, 2012 - Issue 11
261
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Antimalarial activity in Xylocarpus granatum (Koen)

, , , , &
Pages 1012-1015 | Received 26 May 2010, Accepted 05 Sep 2010, Published online: 26 Jul 2011
 

Abstract

The antimalarial activity of Xylocarpus granatum fruits and their active constituents gedunin and xyloccensin-I were investigated using an in vitro model in this study. The chloroform fraction of X. granatum fruits was found to show promising antimalarial activity using an in vitro model of Plasmodium falciparum. On purification of the active fraction, four pure compounds were isolated and characterised, namely gedunin, photogedunin, xyloccensin-I and palmitic acid. Out of these only gedunin and xyloccensin-I were found to show activity equivalent to the parent active fraction in vitro model.

Acknowledgements

We are grateful to the Council of Scientific and industrial Research, New Delhi for providing us excellent research facilities at Central Drug Research Institute Lucknow. We are grateful to the Ministry of Earth Sciences, Government of India, New Delhi for providing financial assistance. We also acknowledge the staff of Sophisticated Analytical Instruments Facilities (SAIF), CDRI, Lucknow for providing spectral data of the compounds for these studies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.